ANDREAS GRASSAUER,EVA PRIESCHL-GRASSAUER -,安德里亞‧格拉索爾,伊娃‧普里斯赫-格拉索爾
申请号：
HK10111173.4
公开号：
HK1144558B
申请日:
2010.12.01
申请国别(地区):
HK
年份:
2014
代理人:
摘要：
The present invention provides for the use of iota- and/or kappa-carrageenan for the manufacture of an antiviral pharmaceutical composition for the prophylaxis or treatment of a pathological condition or disease caused by or associated with an infection by a respiratory virus selected from the group consisting of orthomyxovirus, paramyxovirus, adenovirus and coronavirus. The present invention further provides for the use of fucoidan, in particular of high molecular weight fucoidan, for the manufacture of an antiviral pharmaceutical composition for the prophylaxis or treatment of a pathological condition or disease caused by or associated with an infection by a respiratory virus selected from the group consisting of orthomyxovirus and paramyxovirus.
